Prokidney

Prokidney Equity Ratio

The Equity Ratio of Prokidney (PROK) as of Nov 15, 2026 is -301.33 %. In the previous year, Equity Ratio was -225.58 % — a change of 33.58% (lower).

Equity Ratio

-301.33 %

YoY

33.58%

Last updated:

Equity Ratio of Prokidney is 2025 -301.33 % . Equity Ratio of Prokidney was 2024 -225.58 % . It decreases by 33.58% lower compared to the previous year.

The Prokidney Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2019
81.01 USD
Jan 1, 2020
59.07 USD
Jan 1, 2021
66.79 USD
Jan 1, 2022
-211.70 USD
Jan 1, 2023
-262.37 USD
Jan 1, 2024
-225.58 USD
Jan 1, 2025
-301.33 USD
The Prokidney Equity Ratio history
YEAREquity RatioYoY
-301.33 %+33.58%
-225.58 %-14.02%
-262.37 %+23.93%
-211.70 %-416.95%
66.79 %+13.09%
59.07 %-27.09%
81.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Prokidney Stock analysis

What does Prokidney do? Prokidney Corp, based in Winston-Salem, North Carolina, is a clinical-stage biotechnology company focused on developing cell therapy platforms for chronic kidney diseases. The company employs 231 people and is listed on the stock market since June 30, 2021. Its lead product, Renal Autologous Cell Therapy (REACT), uses a patient's own kidney cells to preserve kidney function in chronic kidney disease patients. REACT is currently in global Phase 3 trials and multiple Phase 2 trials for diabetic kidney disease. Prokidney is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Prokidney stock

Equity Ratio of Prokidney is -301.33 % in 2025.

Equity Ratio of Prokidney changed from -225.58 % to -301.33 %, representing a 33.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Prokidney since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Prokidney with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Prokidney

All Key Metrics — Prokidney